CTIC Annual SG&A
$84.83 M
+$28.63 M+50.95%
31 December 2022
Summary:
As of February 5, 2025, CTIC annual selling, general & administrative expenses is $84.83 million, with the most recent change of +$28.63 million (+50.95%) on December 31, 2022. During the last 3 years, it has risen by +$65.67 million (+342.84%).CTIC Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTIC Quarterly SG&A
$21.91 M
-$1.78 M-7.51%
31 March 2023
Summary:
As of February 5, 2025, CTIC quarterly selling, general & administrative expenses is $21.91 million, with the most recent change of -$1.78 million (-7.51%) on March 31, 2023. Over the past year, it has increased by +$3.87 million (+21.43%).CTIC Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTIC TTM SG&A
-$10.04 B
-$69.24 M-0.69%
31 March 2023
Summary:
As of February 5, 2025, CTIC TTM selling, general & administrative expenses is -$10.04 billion, with the most recent change of -$69.24 million (-0.69%) on March 31, 2023. Over the past year, it has dropped by -$10.11 billion (-15169.10%).CTIC TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTIC Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.0% | +21.4% | -10000.0% |
| 3 y3 years | +342.8% | +390.6% | -10000.0% |
| 5 y5 years | +169.8% | +298.6% | -10000.0% |
CTIC Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | at high | -11.3% | <-9999.0% |
CTI BioPharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $21.91 M(-7.5%) | $88.69 M(+4.6%) |
| Dec 2022 | $84.83 M(+50.9%) | $23.69 M(+10.2%) | $84.83 M(-1.2%) |
| Sept 2022 | - | $21.50 M(-0.4%) | $85.83 M(+10.0%) |
| June 2022 | - | $21.59 M(+19.6%) | $77.99 M(+17.1%) |
| Mar 2022 | - | $18.05 M(-26.9%) | $66.62 M(+18.5%) |
| Dec 2021 | $56.20 M(+218.8%) | $24.69 M(+80.7%) | $56.20 M(+52.7%) |
| Sept 2021 | - | $13.66 M(+33.8%) | $36.81 M(+35.3%) |
| June 2021 | - | $10.21 M(+33.9%) | $27.20 M(+30.9%) |
| Mar 2021 | - | $7.63 M(+43.6%) | $20.79 M(+17.9%) |
| Dec 2020 | $17.63 M(-8.0%) | $5.31 M(+31.0%) | $17.63 M(+4.9%) |
| Sept 2020 | - | $4.05 M(+6.7%) | $16.81 M(-2.0%) |
| June 2020 | - | $3.80 M(-15.0%) | $17.16 M(-6.8%) |
| Mar 2020 | - | $4.47 M(-0.6%) | $18.42 M(-3.9%) |
| Dec 2019 | $19.16 M(-13.2%) | $4.49 M(+2.0%) | $19.16 M(-4.1%) |
| Sept 2019 | - | $4.40 M(-12.9%) | $19.97 M(-6.4%) |
| June 2019 | - | $5.05 M(-2.9%) | $21.33 M(-2.0%) |
| Mar 2019 | - | $5.21 M(-2.0%) | $21.77 M(-1.3%) |
| Dec 2018 | $22.06 M(-29.8%) | $5.31 M(-7.8%) | $22.06 M(-7.0%) |
| Sept 2018 | - | $5.76 M(+5.0%) | $23.73 M(-0.2%) |
| June 2018 | - | $5.49 M(-0.1%) | $23.77 M(-9.4%) |
| Mar 2018 | - | $5.50 M(-21.3%) | $26.24 M(-16.5%) |
| Dec 2017 | $31.43 M(-30.6%) | $6.98 M(+20.4%) | $31.43 M(-6.6%) |
| Sept 2017 | - | $5.80 M(-27.1%) | $33.66 M(-21.9%) |
| June 2017 | - | $7.96 M(-25.5%) | $43.07 M(-3.6%) |
| Mar 2017 | - | $10.69 M(+16.1%) | $44.68 M(-1.4%) |
| Dec 2016 | $45.31 M(-16.0%) | $9.21 M(-39.5%) | $45.31 M(-12.0%) |
| Sept 2016 | - | $15.22 M(+59.0%) | $51.46 M(+3.1%) |
| June 2016 | - | $9.57 M(-15.4%) | $49.92 M(-5.8%) |
| Mar 2016 | - | $11.31 M(-26.3%) | $52.98 M(-1.8%) |
| Dec 2015 | $53.96 M(-4.1%) | $15.36 M(+12.3%) | $53.96 M(+4.3%) |
| Sept 2015 | - | $13.68 M(+8.4%) | $51.74 M(+2.2%) |
| June 2015 | - | $12.62 M(+2.7%) | $50.62 M(-2.3%) |
| Mar 2015 | - | $12.30 M(-6.4%) | $51.79 M(-7.9%) |
| Dec 2014 | $56.24 M(+32.5%) | $13.14 M(+4.6%) | $56.24 M(+0.8%) |
| Sept 2014 | - | $12.56 M(-8.9%) | $55.77 M(+7.8%) |
| June 2014 | - | $13.79 M(-17.7%) | $51.74 M(+7.7%) |
| Mar 2014 | - | $16.75 M(+32.2%) | $48.05 M(+13.2%) |
| Dec 2013 | $42.44 M(+11.0%) | $12.67 M(+48.5%) | $42.44 M(+8.8%) |
| Sept 2013 | - | $8.53 M(-15.6%) | $38.99 M(+2.0%) |
| June 2013 | - | $10.10 M(-9.3%) | $38.23 M(-3.1%) |
| Mar 2013 | - | $11.14 M(+20.9%) | $39.46 M(+3.2%) |
| Dec 2012 | $38.24 M(-0.1%) | $9.22 M(+18.8%) | $38.24 M(-9.0%) |
| Sept 2012 | - | $7.76 M(-31.5%) | $42.02 M(+0.0%) |
| June 2012 | - | $11.33 M(+14.2%) | $42.01 M(+6.0%) |
| Mar 2012 | - | $9.93 M(-23.6%) | $39.64 M(+3.5%) |
| Dec 2011 | $38.29 M(-25.7%) | $12.99 M(+67.4%) | $38.29 M(+2.2%) |
| Sept 2011 | - | $7.76 M(-13.4%) | $37.47 M(-0.4%) |
| June 2011 | - | $8.96 M(+4.5%) | $37.60 M(-9.8%) |
| Mar 2011 | - | $8.58 M(-29.5%) | $41.70 M(-19.1%) |
| Dec 2010 | $51.55 M(-10.7%) | $12.17 M(+54.2%) | $51.55 M(-11.3%) |
| Sept 2010 | - | $7.89 M(-39.6%) | $58.11 M(-16.8%) |
| June 2010 | - | $13.07 M(-29.0%) | $69.88 M(+3.7%) |
| Mar 2010 | - | $18.42 M(-1.7%) | $67.39 M(+16.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $57.73 M(+38.7%) | $18.73 M(-4.8%) | $57.85 M(+15.2%) |
| Sept 2009 | - | $19.67 M(+85.9%) | $50.20 M(+30.8%) |
| June 2009 | - | $10.58 M(+19.2%) | $38.37 M(-2.4%) |
| Mar 2009 | - | $8.87 M(-19.9%) | $39.31 M(-5.6%) |
| Dec 2008 | $41.61 M(+17.8%) | $11.08 M(+41.4%) | $41.64 M(+0.9%) |
| Sept 2008 | - | $7.83 M(-32.0%) | $41.28 M(-2.5%) |
| June 2008 | - | $11.52 M(+2.7%) | $42.32 M(+10.2%) |
| Mar 2008 | - | $11.21 M(+4.6%) | $38.40 M(+8.7%) |
| Dec 2007 | $35.32 M(+0.0%) | $10.72 M(+20.8%) | $35.32 M(+8.8%) |
| Sept 2007 | - | $8.87 M(+16.9%) | $32.45 M(-0.5%) |
| June 2007 | - | $7.59 M(-6.6%) | $32.60 M(-1.8%) |
| Mar 2007 | - | $8.13 M(+3.6%) | $33.21 M(-6.8%) |
| Dec 2006 | $35.30 M(-42.8%) | $7.85 M(-13.1%) | $35.65 M(-11.0%) |
| Sept 2006 | - | $9.03 M(+10.2%) | $40.04 M(-8.0%) |
| June 2006 | - | $8.20 M(-22.4%) | $43.50 M(-17.8%) |
| Mar 2006 | - | $10.56 M(-13.7%) | $52.95 M(-14.2%) |
| Dec 2005 | $61.72 M(-21.4%) | $12.24 M(-2.1%) | $61.72 M(-11.3%) |
| Sept 2005 | - | $12.50 M(-29.2%) | $69.58 M(-8.0%) |
| June 2005 | - | $17.65 M(-8.7%) | $75.63 M(-2.8%) |
| Mar 2005 | - | $19.33 M(-3.9%) | $77.78 M(-0.9%) |
| Dec 2004 | $78.52 M(+41.1%) | $20.11 M(+8.4%) | $78.52 M(+4.8%) |
| Sept 2004 | - | $18.55 M(-6.3%) | $74.96 M(+7.6%) |
| June 2004 | - | $19.80 M(-1.3%) | $69.69 M(+11.2%) |
| Mar 2004 | - | $20.07 M(+21.3%) | $62.70 M(+12.7%) |
| Dec 2003 | $55.64 M(+11.7%) | $16.54 M(+24.5%) | $55.64 M(+4.0%) |
| Sept 2003 | - | $13.28 M(+3.7%) | $53.49 M(+0.3%) |
| June 2003 | - | $12.81 M(-1.5%) | $53.35 M(+3.4%) |
| Mar 2003 | - | $13.01 M(-9.6%) | $51.62 M(+3.7%) |
| Dec 2002 | $49.80 M(+41.2%) | $14.39 M(+9.5%) | $49.80 M(+4.5%) |
| Sept 2002 | - | $13.14 M(+18.7%) | $47.67 M(+9.5%) |
| June 2002 | - | $11.08 M(-1.0%) | $43.54 M(+6.2%) |
| Mar 2002 | - | $11.19 M(-8.7%) | $41.01 M(+16.3%) |
| Dec 2001 | $35.27 M(+72.7%) | $12.26 M(+36.0%) | $35.27 M(+16.0%) |
| Sept 2001 | - | $9.02 M(+5.5%) | $30.41 M(+10.6%) |
| June 2001 | - | $8.55 M(+56.9%) | $27.50 M(+20.1%) |
| Mar 2001 | - | $5.45 M(-26.4%) | $22.89 M(+18.1%) |
| Dec 2000 | $20.42 M(+108.4%) | $7.40 M(+21.2%) | $19.38 M(+33.9%) |
| Sept 2000 | - | $6.11 M(+55.0%) | $14.48 M(+36.9%) |
| June 2000 | - | $3.94 M(+103.8%) | $10.57 M(+9.8%) |
| Mar 2000 | - | $1.93 M(-22.7%) | $9.63 M(-1.7%) |
| Dec 1999 | $9.80 M(-15.5%) | $2.50 M(+13.6%) | $9.80 M(-10.1%) |
| Sept 1999 | - | $2.20 M(-26.7%) | $10.90 M(-3.5%) |
| June 1999 | - | $3.00 M(+42.9%) | $11.30 M(+1.8%) |
| Mar 1999 | - | $2.10 M(-41.7%) | $11.10 M(-4.3%) |
| Dec 1998 | $11.60 M(+14.9%) | $3.60 M(+38.5%) | $11.60 M(0.0%) |
| Sept 1998 | - | $2.60 M(-7.1%) | $11.60 M(+1.8%) |
| June 1998 | - | $2.80 M(+7.7%) | $11.40 M(+6.5%) |
| Mar 1998 | - | $2.60 M(-27.8%) | $10.70 M(+4.9%) |
| Dec 1997 | $10.10 M(+32.9%) | $3.60 M(+50.0%) | $10.20 M(+54.5%) |
| Sept 1997 | - | $2.40 M(+14.3%) | $6.60 M(+57.1%) |
| June 1997 | - | $2.10 M(0.0%) | $4.20 M(+100.0%) |
| Mar 1997 | - | $2.10 M | $2.10 M |
| Dec 1996 | $7.60 M | - | - |
FAQ
- What is CTI BioPharma annual selling, general & administrative expenses?
- What is the all time high annual SG&A for CTI BioPharma?
- What is CTI BioPharma annual SG&A year-on-year change?
- What is CTI BioPharma quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for CTI BioPharma?
- What is CTI BioPharma quarterly SG&A year-on-year change?
- What is CTI BioPharma TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for CTI BioPharma?
- What is CTI BioPharma TTM SG&A year-on-year change?
What is CTI BioPharma annual selling, general & administrative expenses?
The current annual SG&A of CTIC is $84.83 M
What is the all time high annual SG&A for CTI BioPharma?
CTI BioPharma all-time high annual selling, general & administrative expenses is $84.83 M
What is CTI BioPharma annual SG&A year-on-year change?
Over the past year, CTIC annual selling, general & administrative expenses has changed by +$28.63 M (+50.95%)
What is CTI BioPharma quarterly selling, general & administrative expenses?
The current quarterly SG&A of CTIC is $21.91 M
What is the all time high quarterly SG&A for CTI BioPharma?
CTI BioPharma all-time high quarterly selling, general & administrative expenses is $24.69 M
What is CTI BioPharma quarterly SG&A year-on-year change?
Over the past year, CTIC quarterly selling, general & administrative expenses has changed by +$3.87 M (+21.43%)
What is CTI BioPharma TTM selling, general & administrative expenses?
The current TTM SG&A of CTIC is -$10.04 B
What is the all time high TTM SG&A for CTI BioPharma?
CTI BioPharma all-time high TTM selling, general & administrative expenses is $88.69 M
What is CTI BioPharma TTM SG&A year-on-year change?
Over the past year, CTIC TTM selling, general & administrative expenses has changed by -$10.11 B (-15169.10%)